MedPath
HSA Approval

LINCOMYCIN INJECTION 300 mg/ml

SIN01866P

LINCOMYCIN INJECTION 300 mg/ml

LINCOMYCIN INJECTION 300 mg/ml

June 18, 1988

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

J01FF02

lincomycin

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

SHIN POONG PHARMACEUTICAL CO LTD

Active Ingredients

LINCOMYCIN HCl EQV LINCOMYCIN

300 mg/ml

Lincomycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LINCOMYCIN INJECTION 300 mg/ml - HSA Approval | MedPath